# Chiasma, Inc. (CHMA)

Source: https://www.quantisnow.com/company/CHMA
Generated: 2026-11-15T15:37:14.678Z

- Ticker: CHMA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 2015
- Website: chiasma.com

## About

Chiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.

## Latest CHMA news and filings

- 2022-11-03 11:00 UTC [Earnings Date] [Amryt Reports Q3 2022 Financial and Operational Results](https://www.quantisnow.com/insight/amryt-reports-q3-2022-financial-and-operational-results-3622683)
- 2022-08-04 11:00 UTC [Earnings Date] [Amryt Reports Record Q2 2022 Results](https://www.quantisnow.com/insight/amryt-reports-record-q2-2022-results-3235087)
- 2022-07-12 09:00 UTC [Leadership Update] [SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer](https://www.quantisnow.com/insight/spybiotech-appoints-seasoned-biotech-executive-mark-leuchtenberger-as-chief-executive-3129970)
- 2022-05-04 11:00 UTC [Earnings Date] [Amryt Reports Record Q1 2022 Results](https://www.quantisnow.com/insight/amryt-reports-record-q1-2022-results-2824353)
- 2022-03-09 12:00 UTC [Earnings Date] [Amryt Announces 22% growth in FY 2021 Revenues to $222.5M](https://www.quantisnow.com/insight/amryt-announces-22-growth-in-fy-2021-revenues-to-2225m-2544778)
- 2021-08-12 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-chiasma-inc-1659693)
- 2021-08-11 20:31 UTC [SEC Form 15-12B] [SEC Form 15-12B filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-15-12b-filed-by-chiasma-inc-1658014)
- 2021-08-09 21:01 UTC [SEC Form 4] [SEC Form 4: STONEPINE CAPITAL, L.P. returned 6,770,000 units of Common Stock to the company](https://www.quantisnow.com/insight/sec-form-4-stonepine-capital-lp-returned-6770000-units-of-1645662)
- 2021-08-09 20:06 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Chiasma, Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-chiasma-inc-amendment-1644849)
- 2021-08-06 19:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chiasma-inc-1638903)
- 2021-08-06 19:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chiasma-inc-1638902)
- 2021-08-06 19:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chiasma-inc-1638900)
- 2021-08-06 19:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chiasma-inc-1638899)
- 2021-08-06 19:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-chiasma-inc-1638898)
- 2021-08-06 19:12 UTC [SEC Form POS AM filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-chiasma-inc-1638878)
- 2021-08-05 22:05 UTC [SEC Form 4] [SEC Form 4: LUDLAM WILLIAM returned 11,799 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-ludlam-william-returned-11799-units-of-common-1634808)
- 2021-08-05 22:00 UTC [SEC Form 4] [SEC Form 4 filed by Mamluk Roni](https://www.quantisnow.com/insight/sec-form-4-filed-by-mamluk-roni-1634762)
- 2021-08-05 21:58 UTC [SEC Form 4] [SEC Form 4: Minick Scott returned 149,725 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-minick-scott-returned-149725-units-of-common-1634737)
- 2021-08-05 21:57 UTC [SEC Form 4] [SEC Form 4: SCARLETT JOHN A returned 61,322 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-scarlett-john-a-returned-61322-units-of-1634734)
- 2021-08-05 21:51 UTC [SEC Form 4] [SEC Form 4: STACK DAVID M returned 25,000 units of Common Stock to the company](https://www.quantisnow.com/insight/sec-form-4-stack-david-m-returned-25000-units-of-1634697)
- 2021-08-05 21:48 UTC [SEC Form 4] [SEC Form 4 filed by THERO JOHN F](https://www.quantisnow.com/insight/sec-form-4-filed-by-thero-john-f-1634676)
- 2021-08-05 21:46 UTC [SEC Form 4] [SEC Form 4 filed by Varadan Anand](https://www.quantisnow.com/insight/sec-form-4-filed-by-varadan-anand-1634664)
- 2021-08-05 21:37 UTC [SEC Form 4] [SEC Form 4: KANNAN RAJ returned 137,095 units of Common Stock to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-kannan-raj-returned-137095-units-of-common-1634607)
- 2021-08-05 21:33 UTC [SEC Form 4] [SEC Form 4 filed by Geesaman Bard](https://www.quantisnow.com/insight/sec-form-4-filed-by-geesaman-bard-1634602)
- 2021-08-05 21:34 UTC [SEC Form 4] [SEC Form 4 filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-chiasma-inc-1634599)
- 2021-08-05 21:28 UTC [SEC Form 4] [SEC Form 4 filed by Enamait Drew](https://www.quantisnow.com/insight/sec-form-4-filed-by-enamait-drew-1634558)
- 2021-08-05 21:29 UTC [SEC Form 4] [SEC Form 4 filed by Foley Todd](https://www.quantisnow.com/insight/sec-form-4-filed-by-foley-todd-1634547)
- 2021-08-05 21:26 UTC [SEC Form 4] [SEC Form 4 filed by Doyle John Brendan](https://www.quantisnow.com/insight/sec-form-4-filed-by-doyle-john-brendan-1634482)
- 2021-08-05 21:11 UTC [SEC Form 8-K] [Chiasma, Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/chiasma-inc-filed-sec-form-8-k-completion-of-acquisition-or-1634320)
- 2021-08-05 20:03 UTC [SEC Form 25-NSE filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-chiasma-inc-1632785)
- 2021-07-27 14:00 UTC [Leadership Update] [Pulmatrix appoints Director Anand Varadan](https://www.quantisnow.com/insight/pulmatrix-appoints-director-anand-varadan-1509955)
- 2021-07-22 20:46 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-chiasma-inc-1465958)
- 2021-07-02 20:34 UTC [SEC Form 425] [SEC Form 425 filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-chiasma-inc-1243663)
- 2021-07-02 20:32 UTC [SEC Form 8-K] [Chiasma, Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/chiasma-inc-filed-sec-form-8-k-other-events-1243527)
- 2021-07-02 11:27 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-chiasma-inc-1234001)
- 2021-06-28 20:12 UTC [Chiasma Announces Submission of Marketing Authorization Application for MYCAPSSA® to the European Medicines Agency](https://www.quantisnow.com/insight/chiasma-announces-submission-of-marketing-authorization-application-for-mycapssa-to-1174110)
- 2021-06-24 20:29 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-chiasma-inc-1139689)
- 2021-06-22 20:36 UTC [SEC Form 425] [SEC Form 425 filed by Chiasma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-chiasma-inc-1106672)
- 2021-06-22 20:32 UTC [SEC Form 8-K] [Chiasma, Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/chiasma-inc-filed-sec-form-8-k-other-events-1106542)
- 2021-06-15 10:45 UTC [Amryt Pharma Announces Filing of Preliminary Registration Statement on Form F-4 in Connection with Its Proposed Acquisition of Chiasma, Inc.](https://www.quantisnow.com/insight/amryt-pharma-announces-filing-of-preliminary-registration-statement-on-form-1012958)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CHMA
- Earnings history: https://www.quantisnow.com/earnings/CHMA
- Dividend history: https://www.quantisnow.com/dividends/CHMA
- Insider transactions: https://www.quantisnow.com/insiders/CHMA
- Options chain: https://www.quantisnow.com/options/CHMA
- SEC 8-K filings only: https://www.quantisnow.com/company/CHMA/8-k
- RSS and alerts for CHMA: https://www.quantisnow.com/docs/rss-feeds.md